Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
SSMXY SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS
31.820
+1.130+3.68%
YOY
Do not show
Hide blank lines
(Q2)2022/09/30(Q1)2022/06/30(FY)2022/03/31(Q4)2022/03/31
Total revenue
20.81% 107.99B 8.40% 86.03B 19.24% 363.78B 12.50% 104.88B
Operating revenue
20.81% 107.99B 8.40% 86.03B 19.24% 363.78B 12.50% 104.88B
Cost of revenue
26.44% 52.42B 14.92% 43.07B 14.87% 173.2B 8.72% 51.67B
Gross profit
15.94% 55.58B 2.56% 42.96B 23.51% 190.59B 16.44% 53.21B
Operating expense
14.37% 33.48B 18.91% 31.91B 20.15% 123.17B 19.62% 35.66B
Selling and administrative expenses
23.33% 27.83B 16.99% 25.16B 16.57% 94.24B 19.19% 26.98B
-General and administrative expense
23.33% 27.83B 16.99% 25.16B 16.57% 94.24B 19.19% 26.98B
Research and development costs
24.46% 7.61B 25.88% 6.92B 18.95% 26.78B 16.91% 8.47B
Other operating expenses
-81.86% 214M 185.23% 251M 350.25% 3.56B 34.68% 501M
Operating profit
18.42% 22.1B -26.57% 11.05B 30.17% 67.42B 10.46% 17.55B
Net non-operating interest income expense
-17.81% -86M -339.36% -413M 19.51% -359M -172.22% -196M
Non-operating interest income
85.43% 280M 50.98% 154M 30.95% 550M -41.90% 104M
Non-operating interest expense
63.39% 366M 189.29% 567M 4.97% 909M 19.52% 300M
Other net income (expense)
Income before tax
23.74% 21.7B -11.72% 12.85B 33.96% 64.35B 10.40% 16.28B
Income tax
8.34% 5.77B 5.11% 4.85B 35.79% 20.27B 3.68% 4.99B
Net income
30.47% 15.93B -19.54% 7.99B 33.13% 44.07B 13.64% 11.29B
Net income continuous Operations
30.46% 15.93B -19.55% 7.99B 33.14% 44.07B 13.66% 11.29B
Minority interest income
26.19% -31M 36.21% -37M 46.15% -21M 23.08% 96M
Net income attributable to the parent company
30.28% 15.96B -19.64% 8.03B 33.04% 44.09B 13.57% 11.19B
Preferred stock dividends
Other preferred stock dividends
0 0 -1M -1M
Net income attributable to common stockholders
30.28% 15.96B -19.64% 8.03B 33.04% 44.09B 13.58% 11.19B
Basic earnings per share
30.15% 38.14 -19.72% 19.19 32.92% 105.44 13.44% 26.75
Diluted earnings per share
30.37% 38.12 -19.59% 19.185 32.89% 105.245 13.58% 26.72
Dividend per share
16.24% 21.2509 0 -0.70% 35.8474 -1.88% 17.5654
Currency Unit
JPYJPYJPYJPY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
CEO: Mr. Hisashi Ietsugu
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist